DermTest Company
%20.jpg)
Dermtest is a doctor-to-doctor telemedicine platform empowering family doctors to provide high quality skin-cancer early detection service. Dermtest enables discovering early changes in moles that may develop into malignant skin tumors. The system combines teledermatology software and diagnostic hardware into a complete solution, including telemedicine, m-health and personalized medicine components. The core of the Dermtest product is a teledermoscopy system with decision support, connecting family doctors with dermatologists for providing access to a dermatologist consultation at a patient’s local primary care clinic.
Total Funding:
$441K
Headquarters:
Europe
Funding Status:
Seed
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Last Funding Type:
Grant
Technology:
TeleHealth
Investor Type:
For Profit
Investors Number:
4
Founded Date:
2013-01-01
Industry:
AgeTech